The virus filtration market is expected to observe good growth over the forecast period. The major factors attributing to the growth of the virus filtration market are increasing R&D spending, growth in the biopharmaceutical industry, and the adoption of single-use technologies. Also, factors such as the increasing prevalence of chronic diseases are contributing to the growth of the market. The increasing prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders, are anticipated to propel the demand for biologics. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. This raises the research and development expenditures by biopharmaceutical companies to bring more innovation where virus filtration techniques are highly useful. These factors promote the growth of the virus filtration market.

Key Market Trends

The Kits, Reagents, and Consumables Segment is Expected to Hold the Majority Share of the Market

The kits, reagents, and consumables segment serves as an important category in the virus filtration market. The reagents help to reduce the potential of iatrogenic transmission of pathogenic viruses. In the process evaluation, the reagents help to identify the virus that is likely to contaminate the cell-substrate or any other reagents or materials used in the process.

Qiagen and Merck Millipore are two of the widely known companies for reagents and kits for virus filtration. The samples used in the biopharmaceuticals production may include blood, plasma, serum, or bodily fluids, or any monoclonal antibody and recombinant proteins. Even several biologic and pharmaceutical-based companies are opting to invest more in R&D of vaccines, protein therapeutics, blood products, cellular therapy products, gene therapy products, tissue products, and stem cell products. The demand for these kits and reagents is driving the market studied.

North America Dominates the Market and Expected to do Similar Over the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing incidence of diseases and the presence of more number of pharmaceutical companies in the region. In the North American region, the United States holds the largest market share. Additionally, in recent years, there has been increased regulatory scrutiny of incidents related to adventitious viruses in manufacturing processes. Owing to the increased R&D of biopharmaceutical companies, the demand for biologics is expected to drive the viral filtration market, during the forecast period.

Competitive Landscape

The virus filtration market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market studied. With the rising R&D of biopharmaceutical companies and the high prevalence of diseases, few other smaller players are expected to enter into the market studied in the coming years. Some of the major players of the market studied are Asahi Kasei Medical Co. Ltd, Charles River Laboratories International Inc., General Electric Company, Pall Corporation, and Merck KgaA, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support